Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Benchling, Faire, and 370+ companies. 5-min read every Tuesday.
Benchling is the R&D cloud platform for life sciences teams to design, track, and analyze experiments — the operating system for biotech and pharmaceutical R&D globally. Valued at $6.1B with $500M+ raised, Benchling is used by 10 of the top 20 pharmaceutical companies including Pfizer, Novartis, and Regeneron. Major healthtech IPO candidate competing with Schrödinger and Dotmatics in the $30B+ life sciences software market.
| Industry | Biotechnology |
| Stage | Public |
| IPO Status | Public |
| Valuation | $8.5B |
| Total Funding | $912M |
| Headquarters | San Francisco, CA |
Faire is the wholesale marketplace connecting 700K+ independent retailers with 100K+ emerging brands — the B2B commerce platform for the indie retail economy. Valued at $12.4B with $1.7B raised, Faire processes billions in annual GMV and is the dominant wholesale marketplace globally. IPO candidate as B2B commerce digitisation continues to disrupt traditional wholesale distribution — a $50B+ global market.
| Industry | E-commerce |
| Stage | Series H |
| IPO Status | Private |
| Valuation | $12.4B |
| Total Funding | $1.7B |
| Headquarters | San Francisco, CA |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Benchling is valued at $8.5B. Faire is valued at $12.4B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Benchling filed an S-1 in May 2026 and is actively in the IPO pipeline. Faire filed an S-1 in April 2026 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Benchling has raised $912M. Faire has raised $1.7B.
Benchling operates in Biotechnology, while Faire operates in E-commerce.
Benchling is a Biotechnology company valued at $8.5B with $912M raised. Faire is a E-commerce company valued at $12.4B with $1.7B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Benchling and Faire through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.